The global albumin market is likely to gain traction from the rising usage of recombinant DNA technology to safely produce significant proteins and other components in the laboratory setting. This information is given by Fortune Business Insights™ in a recent study, titled, “Albumin Market Size, Share & Industry Analysis, By Product (Human Serum Albumin (HSA), Recombinant Albumin, and Bovine Serum Albumin (BSA)), By Application (Therapeutics, Diagnostics, and Research) By End User (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2019-2026.” The study further states that the albumin market size was USD 4.29 billion in 2018 and is projected to reach USD 6.77 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period.
What Does This Report Contain?
- In-depth information about albumin market trends, growth drivers, and barriers.
- Competitive landscape including mergers and acquisitions, collaborations and partnerships, innovative product launches, investments, agreements, and contracts.
- Extensive analysis of the dominant region present in the market.
- Profiles of all the renowned organizations and the strategies that they are following to generate more sales.
- List of all the segments.
The COVID-19 pandemic has caused huge losses for several companies by halting their manufacturing processes. The governments of various companies are persistently striving to prevent the transmission of coronavirus by promoting social distancing and sanitization measures. Our reports would help you in gaining more insights into the effects of COVID-19 on every market.
The Albumin Market report offers an in-depth analysis of the Albumin industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Albumin market concentration, and maturity analysis is elaborated in this report.
Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.
The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Albumin Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.
Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Albumin Market Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Request Sample PDF:
https://www.fortunebusinessinsights.com/enquiry/sample/albumin-market-102637
Drivers & Restraints-
Development of Fractionation Facilitiesto Skyrocket Demand
Usage of protein is upsurging day by day owing to their possession of several advantages. They are mainly used in the development of crucial drugs. Italy, the U.S., and Belgium, for instance, are exhibiting high demand for protein. It is, in turn, leading to the construction ofmultiple fractionation facilities for keeping up with the demand and supply balance. These facilities help in fragmenting plasma into albumin and other components. Development of such facilities is aiding the biotechnology and pharmaceutical industries in creating state-of-the-art productsfor research, diagnostics, and therapeutics applications. However, unavailability of therapeutic products may hinder market growth.
Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
Regional Segments-
Therapeutic Segment to Dominate Owing to Rising Prevalence of Hypovolemia
Based on application, the market is grouped into diagnostics, research, and therapeutics. Amongst these, the therapeutics segment held 66.4% albumin market share in 2018. This segment is likely to remain in the dominant position throughout the forecast period stoked by the increasing prevalence of hypovolemia and other similar disorders. Therefore, the sales of drugs for treating these disorders are also rising. Companies, such as CSL Limited and Takeda are the major contributors to growth of this segment by developing innovative plasma-derived products. Several pharmaceutical, as well as biotechnology companies are also investing huge sums in research and development activities to unveil new therapeutic products.
The Report offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Albumin market to figure out and study the market’s needs, market size, and competition.
Regional Analysis-
Increasing Sales of Drugs in China to Favor Growth in Asia Pacific
Geographically, the market is segregated into Latin America, the Middle East and Africa, North America, Europe, and Asia Pacific. Asia Pacific generated USD 2.39 billion in 2018 in terms of albumin market revenue. This growth is mainly attributable to the expansion of plasma fractionation facilities, as well as increasing sale of drugs in China. The country is considered to house the largest market because it has imposed high prices on its products. In North America and Europe, the market is likely to experience a comparatively lower CAGR fueled by the availability of drugs and the existence of unique healthcare facilities.
Competitive Landscape-
Major companies in the Global Albumin Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Healthcare Industry.
Major Players Aim to Acquire Other Companies to Strengthen Position
The market is highly fragmented and competitive. CSL Limited is one of the leading organizations possessing around 30% of the global market share. This growth is attributable to the organization’s adoption of the acquisition strategy with several China-based companies. Other, namely, Grifols, S.A. and Takeda are persistently investing huge sums in research and development activities to open new facilities. Below are a couple of the latest industry developments:
- October 2017: Green Cross Biotherapeutics Inc. started a new innovative biomanufacturing facility in North America and Montreal. It is equipped with state-of-the-art equipment and produces plasma-derived products, especially for albumin and intravenous immunoglobulin (IVIg).
- October 2017: The U.S. FDA approved LUCICA glycated albumin–L, an in-vitro diagnostic assay kit meant for glycated albumin. It was developed by Asahi Kasei Pharma.
Check discount:
https://www.fortunebusinessinsights.com/enquiry/check-discount/albumin-market-102637
Fortune Business Insights™ lists out some of the most prominent companies operating in the albumin market. They are as follows:
- Kedrion S.p.A
- Octapharma AG
- Biotest AG
- Takeda Pharmaceutical Company Limited
- CSL Limited
- Merck KGaA
- Grifols, S.A
- Seracare Life Sciences
- Novozymes
- Other prominent players
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- New Product Launch
- Pipeline Analysis
- Overview: Trends in Albumin Market
- Prevalence of Related Disorders – By Key Countries
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
- Global Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Geography
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
- North America Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Europe Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Country/Sub-region
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Country/Sub-region
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Country/Sub-region
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa Albumin Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Human Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Diagnostics
- Research
- Market Analysis, Insights and Forecast – By End User
- Hospital & Clinics
- Pharmaceutical & Biotechnology Industry
- Research Institutes
- Market Analysis, Insights and Forecast – By Country/Sub-region
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- Competitive Analysis
- Key Industry Developments
- Global Market Share Analysis (2018)
- Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- CSL Limited
-
-
- Takeda Pharmaceutical Company Limited
- Grifols, S.A
- Octapharma AG
- Kedrion S.p.A
- Merck KGaA
- Novozymes
- Biotest AG
- SERACARE LIFE SCIENCES
- Other Prominent Players
-
- Strategic Recommendations
List of Figures
Figure 1: Global Albumin Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026
Figure 2: Global Albumin Market Value Share (%), by Product, 2018 & 2026
Figure 3: Global Albumin Market Forecast (US$ Mn), by Human Serum Albumin, 2015-2026
Figure 4: Global Albumin Market Forecast (US$ Mn), by Recombinant Albumin, 2015-2026
Figure 5: Global Albumin Market Forecast (US$ Mn), by Bovine Serum Albumin, 2015-2026
Figure 6: Global Albumin Market Value Share (%), by Application, 2018 & 2026
Figure 7: Global Albumin Market Forecast (US$ Mn), by Therapeutics, 2015-2026
Figure 8: Global Albumin Market Forecast (US$ Mn), by Diagnostics, 2015-2026
Figure 9: Global Albumin Market Forecast (US$ Mn), by Research, 2015-2026
Figure 10: Global Albumin Market Value Share (%), by End-user, 2018 & 2026
Figure 11: Global Albumin Market Forecast (US$ Mn), by Hospitals & Clinics, 2015-2026
Figure 12: Global Albumin Market Forecast (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2015-2026
Figure 13: Global Albumin Market Forecast (US$ Mn), by Research Institutes, 2015-2026
Figure 14: Global Albumin Market Value (US$ Mn), by Region, 2018 & 2026
Figure 15: North America Albumin Market Value (US$ Mn), by Product, 2018 & 2026
Figure 16: North America Albumin Market Value Share (%), by Product, 2018
Figure 17: North America Albumin Market Value (US$ Mn), by Application, 2018 & 2026
Figure 18: North America Albumin Market Value Share (%), by Application, 2018
Figure 19: North America Albumin Market Value (US$ Mn), by End-user, 2018 & 2026
Figure 20: North America Albumin Market Value Share (%), by End-user, 2018
Figure 21: North America Albumin Market Value (US$ Mn), By Country, 2018 & 2026
Figure 22: North America Albumin Market Value Share (%), By Country, 2018
Figure 23: Europe Albumin Market Value (US$ Mn), by Product, 2018 & 2026
Figure 24: Europe Albumin Market Value Share (%), by Product, 2018
Figure 25: Europe Albumin Market Value (US$ Mn), by Application, 2018 & 2026
Figure 26: Europe Albumin Market Value Share (%), by Application, 2018
Figure 27: Europe Albumin Market Value (US$ Mn), by End-user, 2018 & 2026
Figure 28: Europe Albumin Market Value Share (%), by End-user, 2018
Figure 29: Europe Albumin Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026
Figure 30: Europe Albumin Market Value Share (%), By Country/ Sub-region, 2018
Figure 31: Asia Pacific Albumin Market Value (US$ Mn), by Product, 2018 & 2026
Figure 32: Asia Pacific Albumin Market Value Share (%), by Product, 2018
Figure 33: Asia Pacific Albumin Market Value (US$ Mn), by Application, 2018 & 2026
Figure 34: Asia Pacific Albumin Market Value Share (%), by Application, 2018
Figure 35: Asia Pacific Albumin Market Value (US$ Mn), by End-user, 2018 & 2026
Figure 36: Asia Pacific Albumin Market Value Share (%), by End-user, 2018
Figure 37: Asia Pacific Albumin Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026
Figure 38: Asia Pacific Albumin Market Value Share (%), By Country/ Sub-region, 2018
Figure 39: Latin America Albumin Market Value (US$ Mn), by Product, 2018 & 2026
Figure 40: Latin America Albumin Market Value Share (%), by Product, 2018
Figure 41: Latin America Albumin Market Value (US$ Mn), by Application, 2018 & 2026
Figure 42: Latin America Albumin Market Value Share (%), by Application, 2018
Figure 43: Latin America Albumin Market Value (US$ Mn), by End-user, 2018 & 2026
Figure 44: Latin America Albumin Market Value Share (%), by End-user, 2018
Figure 45: Latin America Albumin Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026
Figure 46: Latin America Albumin Market Value Share (%), By Country/ Sub-region, 2018
Figure 47: Middle East & Africa Albumin Market Value (US$ Mn), by Product, 2018 & 2026
Figure 48: Middle East & Africa Albumin Market Value Share (%), by Product, 2018
Figure 49: Middle East & Africa Albumin Market Value (US$ Mn), by Application, 2018 & 2026
Figure 50: Middle East & Africa Albumin Market Value Share (%), by Application, 2018
Figure 51: Middle East & Africa Albumin Market Value (US$ Mn), by End-user, 2018 & 2026
Figure 52: Middle East & Africa Albumin Market Value Share (%), by End-user, 2018
Figure 53: Middle East & Africa Albumin Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026
Figure 54: Middle East & Africa Albumin Market Value Share (%), By Country/ Sub-region, 2018
Figure 55: Global Albumin Market Share (%), By Company, 2018
List of Tables
Table 1: Global Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015–2026
Table 2: Global Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015–2026
Table 3: Global Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015–2026
Table 4: Global Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015–2026
Table 5: Global Albumin Market Revenue (US$ Mn) Forecast, by Region, 2015-2026
Table 6: North America Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015-2026
Table 7: North America Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015-2026
Table 8: North America Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015-2026
Table 9: North America Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026
Table 10: North America Albumin Market Revenue (US$ Mn) Forecast, By Country, 2015-2026
Table 11: Europe Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015-2026
Table 12: Europe Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015-2026
Table 13: Europe Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015-2026
Table 14: Europe Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026
Table 15: Europe Albumin Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026
Table 16: Asia Pacific Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015-2026
Table 17: Asia Pacific Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015-2026
Table 18: Asia Pacific Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015-2026
Table 19: Asia Pacific Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026
Table 20: Asia Pacific Albumin Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026
Table 21: Latin America Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015-2026
Table 22: Latin America Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015-2026
Table 23: Latin America Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015-2026
Table 24: Latin America Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026
Table 25: Latin America Albumin Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026
Table 26: Middle East & Africa Albumin Market Revenue (US$ Mn) Forecast, by Product, 2015-2026
Table 27: Middle East & Africa Albumin Market Revenue (US$ Mn) Forecast, by Application, 2015-2026
Table 28: Middle East & Africa Albumin Market Revenue (US$ Mn) Forecast, by Modality, 2015-2026
Table 29: Middle East & Africa Albumin Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026
Table 30: Middle East & Africa Albumin Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026
Browse more info on this Report:
https://www.fortunebusinessinsights.com/albumin-market-102637
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Author’s Bio –
Name: Reeti Banerjee
Reeti Banerjee is currently working as a content writer in a prominent market research firm named Fortune Business Insights™. She specializes in writing articles, press releases, blogs, and news reports. She believes in maintaining simplicity throughout her content to provide the clients with a seamless reading experience.